Overview

Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia

Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I/II trial to study the effectiveness of CC-1088 in treating patients who have chronic lymphocytic leukemia that has not responded to previous therapy.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Boston Medical Center